In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon charges

This article was originally published in The Rose Sheet

Executive Summary

Savings of approximately $15 mil. pretax in 2003 and $40 mil.-$50 mil. in 2004 will be recorded as benefit of $43.6 mil. pretax charge scheduled to be taken in third quarter, direct-seller announces Oct. 2. Charge, which is part of Avon's business transformation initiative, will cover "severance expense in the areas of organization structure and supply chain in all geographic regions," company explains. Avon also will record $7.3 mil. pretax gain in the quarter due to an adjustment in a charge recorded in fourth quarter 2001...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010642

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel